You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中生製藥(01177.HK)續挫逾8% 全年多賺逾4倍末期息4港仙
阿思達克 04-01 11:57
藍籌中生製藥(01177.HK)全年多賺逾4倍並派末期息4港仙,該股繼昨天回吐結束三連升後,今早一舉跌破20天及10天線(4.58元及4.85元),最低見4.46元,現報4.49元,續挫8.1%,爲最傷藍籌,成交增至5,322萬股。 中生製藥昨天收市後公佈,去年純利按年升近4.3倍至164.1億元人民幣(超過盈喜時預測逾140億元人民幣),每股盈利約77.83分人民幣,末期股息按年倍增至4港仙。期內,總收入按年增加13.6%至268.6億元人民幣。至於去年基本盈利按年增長26.6%至29.3億元人民幣。此外,公司擬於未來一年斥最多10億元回購股份。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account